222714-33-2

Basic information

• Product Name: (S)-4-(1-AMINOETHYL)BENZOIC ACID
• Synonyms: 4-[(1S)-1-AMINOETHYL]-BENZOIC ACID;(S)-4-(1-AMINOETHYL)BENZOIC ACID;Benzoic acid, 4-[(1S)-1-aminoethyl]-;4-[(1S)-1-aMinoethyl]-;(S)-4-(1-aminoethyl)benzoic acid HCl
• CAS NO: 222714-33-2
• Molecular Formula: C₉H₁₁NO₂
• Molecular Weight: 165.19
• Product Categories: API intermediates
• Mol File: 222714-33-2.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 317°C at 760 mmHg
• Flash Point: 145.5°C
• Appearance: /
• Density: 1.186g/cm³
• Vapor Pressure: 0.000166mmHg at 25°C
• Refractive Index: 1.579
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 4.02±0.10(Predicted)
• CAS DataBase Reference: (S)-4-(1-AMINOETHYL)BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-(1-AMINOETHYL)BENZOIC ACID(222714-33-2)
• EPA Substance Registry System: (S)-4-(1-AMINOETHYL)BENZOIC ACID(222714-33-2)

Safety Data

• Hazardous Substances Data: 222714-33-2(Hazardous Substances Data)

Usage

General Description

(S)-4-(1-aminoethyl)benzoic acid is a chemical compound that belongs to the class of amino acids. It is an organic compound with a molecular formula C9H11NO2 and a molecular weight of 165.19 g/mol. (S)-4-(1-AMINOETHYL)BENZOIC ACID is a derivative of the amino acid phenylalanine, with a small modification in its structure to incorporate an additional amino group attached to the carbon atom of the benzene ring via a two-carbon linker. (S)-4-(1-AMINOETHYL)BENZOIC ACID is of interest in pharmaceutical research and drug development due to its potential therapeutic applications, particularly in the field of neuropharmacology, as it can act as a neurotransmitter precursor and modulator. Additionally, it may also have potential applications as a building block for the synthesis of various bioactive compounds.

InChI:InChI=1/C9H11NO2/c1-6(10)7-2-4-8(5-3-7)9(11)12/h2-6H,10H2,1H3,(H,11,12)/t6-/m0/s1

Downstream Products

• 222714-37-6 4-[(1S)-1-aminoethyl]-benzoic acid, methyl ester 
• 847729-04-8 tert-butyl 4-[(1S)-1-[(2,5-dichloropyridin-3-yl)formamido]ethyl]benzoate 
• 847729-01-5 (S)-tert-butyl 4-[1-(benzyloxycarbonylamino)ethyl]benzoate 
• 847729-02-6 tert-butyl 4-[(1S)-1-aminoethyl]benzoate 
• 1362627-51-7 C₂₃H₃₀N₂O₅ 
• 847729-00-4 (S)-4-[1-(benzyloxycarbonylamino)ethyl]benzoic acid 

Relevant articles and documents

Piperazine compounds and medicinal use thereof

The present invention relates to a piperazine compound of the formula wherein R1and R2are each hydrogen, halogen, lower alkyl, lower alkoxy, amino, substituted amino, nitro, hydroxy or cyano, R3, R4and R5are each hydrogen, halogen, lower alkyl, lower alkoxy, nitro, amino, substituted amino or hydroxy, R6and R7are each hydrogen, lower alkyl, lower alkyl substituted by halogen, aralkyl, acyl or lower acyl substituted by halogen, R8and R9are each hydrogen or lower alkyl, Y is lower alkylene and the like, and ring A is phenyl, pyrimidyl, thiazolyl, pyridyl, pyrazyl or imidazolyl, a pharmaceutically acceptable salt thereof and pharmaceutical agents containing these compounds. The compound of the present invention has superior TNF-α production inhibitory effect and/or IL-10 production promoting effect, and, since it is free of or shows only strikingly reduced expression of an effect on the central nervous system, the compound is useful as a highly safe and superior TNF-α production inhibitor an/or IL-10 production promoter and is useful as an agent for the prophylaxis or treatment of various diseases caused by abnormal TNF-α production, diseases curable with IL-10, such as chronic inflammatory diseases, acute inflammatory diseases, inflammatory diseases due to infection, autoimmune diseases, allergic diseases, and TNF-α mediated diseases.